ECMO therapy helps to recover lung function in a majority of patients during COVID-19 pandemic
Chennai: November 17 2021: Apollo Hospitals, Chennai is the pioneer (since 2010) in utilizing extracorporeal membrane oxygenation (ECMO). During the brutal second wave of Covid-19, the team broke records by succes sfully helping lung function to recover in the largest number of patients in India.
What is ECMO? The patient’s blood is purified and oxygenated through large tubes placed inside large veins (clo se to the heart) and returned back by means of a pump. In the majority of patients who have COVID-19 that causes lung failure, only lung support is required. In a small number of patients, it is required for the support of the heart function also.
Apollo Hospitals in Chennai has the country’s most advanced ECMO unit, which has successfully treated over 27 0 ECMO patients since 2010. ECMO is employed in a variety of situations, including poisoning, trauma, and infe ctions such as H1N1, pre and post-transplant patients and most recently, COVID -19. We have demons tra ted th at ECMO was very effective in patients who were unable to be treated with conventional ventilator ther apy. Am ong the many records the Apollo Chennai ECMO unit has set, we also have the longest bridge to lung rec overy patient on ECMO for 116 days (183 days of hospitalisation). In addition, some of the other records include long est average stay 60 days, and the most number of patients who have recovered normal lung function after three months.
Sharing insights with the media Dr. Paul Ramesh, Senior Consultant Cardiothoracic and Heart and Lung Transpl ant Surgeon, Apollo Hospitals, said “The average period on ECMO prior to discharge is 60 days. The current survi val rate (at 6 months) for ECMO patients is 73.9 percent, which is higher than the global average of 40-50 perce nt. One of the most effective outcomes of Apollo Hospitals’ ECMO programme is a patient who was on ECMO for 116 days, the longest bridge to recovery in India. By using ECMO we have seen that the majority of patients with significant lung injury recover fully, eliminating the need for a lung transplant.”
He also added, “Of the 23 persons infected during the second wave of covid-19 with the delta variant placed on ECMO, ten patients have been discharged, one patient had a successful transplant, two patients are off ECMO and undergoing rehabilitation, and we lost six patients due to severe illness.”
Dr. K. Madhankumar, Senior Consultant Cardiothoracic and Heart and Lung Transplant Surgeon, Apollo Hosp ita ls, said, “The reasons for our team’s success include awake ECMO, which allows patients to remain awake and en gage with their families, which boosts their morale and enhances the likelihood of a faster recovery and better treatment outcomes. Patients on ECMO are urged to exercise on a regular basis, and physiotherapy is provided to fully mobilize them quickly after they have been removed from the machine.”
Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group said, “In order to establish a state of the art EC MO unit that can deliver outcomes on par with the best units in the world, many streams of expertise, kn owl ed ge and skill from medical, nursing, perfusion technology as well as management and administrative streams have to come together. It is with a deep satisfaction that I acknowledge that has happened at a time when it was nee ded the most.”
About Apollo Hospitals:
It was in 1983, that Dr. Prathap C Reddy made a pioneering endeavour by launching India’s first corporate hosp ital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence incl udes over 12,000 beds across 72 Hospitals, 3800+ Pharmacies, over 90 Primary Care clinics and 650 Diagnostic centers, 148 plus Telemedicine Centres, over 15 medical education centres and a Research Foundation with a foc us on global Clinical Trials, epidemiological studies, stem cell & genetic research, Apollo Hospitals has been at the forefront of new medical advancements with the most recent investment being the commissioning of Sou th East Asia’s very first Proton Therapy Centre in Chennai. Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contr ibution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For 37 years, the Apollo Hospitals Group has continuously exce lled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.
